BIM-018

BIM-018
Systematic (IUPAC) name
2-(naphthalene-1-carbonyl)-1-pentyl-1H-1,3-benzodiazole
Clinical data
Legal status
Identifiers
ChemSpider 29763750
Chemical data
Formula C23H22N2O
Molar mass 342.4 g/mol

BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]

See also

References

  1. "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
  2. Daniel Pagé, Elise Balaux, Luc Boisvert, Ziping Liu, Claire Milburn, Maxime Tremblay, Zhongyong Wei, Simon Woo, Xuehong Luo, Yun-Xing Cheng, Hua Yang, Sanjay Srivastava, Fei Zhou, William Brown, Miroslaw Tomaszewski, Christopher Walpole, Leila Hodzic, Stéphane St-Onge, Claude Godbout, Dominic Salois, Keymal Payza (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters 18 (13): 3695–3700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.



This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.